NEW YORK, Nov. 2, 2016 /PRNewswire/ -- Revenue Forecasting of Originator, Generic and OTC Medicines and Therapy Areas Including CNS, Cardiovascular and Cancer; Exploration of Regional Differences in Healthcare; Discussion of Domestic Manufacturers Including EMS, Hypermarcas and Aché, and International Drug Companies Including Sanofi, Novartis and Roche Report Details Medicine Sales in Brazil - How to Find Trends, Opportunities and Forecasted RevenuesDo you want to assess Brazil's pharmaceutical market from 2016? If so, visiongain's new report gives you revenue forecasts, helping your research and analysis. That study's purpose is to show opportunities, trends and sales predictions to 2026.Brazil can satisfy expectations for wider healthcare coverage and rapid expansion of its pharma industry and market. With our updated study you explore business analysis, developments and opportunities for domestic and foreign companies.Please read on to explore Brazilian medical sales and see how high that fast developing country's revenues could go.Trends and outlooks for that emerging healthcare market - what is possible?From 2016 patients, treatment providers and the pharmaceutical industry will benefit from progress in Brazilian healthcare. Discover in our study what the future holds - medical needs and potential revenues. Also find rankings of companies. Our new analysis shows you revenue predictions from 2016 to 2026 at overall national and submarket levels. You discover the most lucrative parts of that country's drug market, seeing opportunities to benefit patients, healthcare providers and pharma companies. Explore what the future holds for domestic producers and multinational pharma companies. Forecasts and other data help you find where the money lies in Brazil's medical salesTo support our forecasting, our work shows you historical results, sales growth rates and market shares. In our 191 page report you gain 52 tables, 55 charts and interviews with representatives from BiocadBrazil Farmaceutica and Sandoz Brazil.With our study, see how you could save time and avoid struggles to find data to help your research, analysis, plans and presentations. See, too, how you could help your influence, benefiting your reputation for commercial insight on Brazilian pharma.The following sections show how our investigation helps your work. Potential of Brazil's drug sales - overall market and segment forecastsWhat is Brazil's potential as a pharma market? In our analysis you discover overall revenues to 2026, with discussions. Our report also shows you individual sales predictions - from 2016 to 2026 - for three main submarkets:• Patented therapies - original brands of prescription drugs• Generic pharmaceuticals (generics)• OTC medicines - over-the-counter treatments.The future looks promising for Brazilian pharmaceutical sales. That developing national market is growing at a faster rate than more-mature markets, and can continue to do so over the next ten years. See what is possible.With our study also extend your knowledge of that country's medical needs and pharma industry. In addition you explore forecasting for therapeutic applications, assessing demand and potential revenues. Diseases and their treatment - what prospects for drugs and their sellers?Our new study also predicts revenues in Brazil for treating prominent diseases. See individual revenue forecasts to 2026 for six therapeutic categories:• Central nervous system (CNS)• Cardiovascular (CV)• Gastrointestinal and metabolic• Cancer treatments (oncology)• Infectious diseases - anti-infective agents (vaccines and antibiotics)• Therapies for other disorders (grouped analysis).How fast will those submarkets expand? How high will their revenues go? With our report you assess opportunities and potentials, seeing what developments and sales are possible.There you also investigate what stimulates and restrains sales of drugs.